Skip to search formSkip to main contentSkip to account menu

temozolomide 180 MG Oral Capsule

Known as: TEMOZOLOMIDE 180 mg ORAL CAPSULE [Temozolomide], TEMOZOLOMIDE 180MG CAP, TEMOZOLOMIDE 180MG CAP [VA Product] 
National Institutes of Health

Related topics

Related topics

45 relations
1-ButanolAlkylating Activity [MoA]Allura Red AC DyeAluminum Oxide

Broader (1)

Antineoplastic Agents, Alkylating

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Meningeal seeding fromglioblastoma multiforme treated with radiotherapyand temozolomide
2013
2013
Abstract 2414: A phase I/II clinical trial to evaluate the efficacy of combined epigenetic therapy for improving temozolomide chemosensitivity in metastatic melanoma.
Background: Cancer epigenomes are characterized by global changes in DNA methylation and covalent histone modification patterns… 
2010
2010
Gamma Knife Radiosurgery for Recurrent Glioblastoma Resistance to the Temozolomide
Purpose: The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by… 
2004
2004
Glioblastoma by Temozolomide in Experimental α Necrosis Factor Transcriptional Targeting of Adenovirally Delivered Tumor
Temozolomide is an oral alkylating agent shown to have modest efficacy in the treatment of glioblastoma multiforme. Tumor… 
2003
2003
Formulations pharmaceutiques d'agents anti-néoplastiques, notamment la temozolomide, et procédés de fabrication et d'utilisation associés
Plusieurs modes de realisation de l'invention concernent une formulation pharmaceutique comprenant au moins un agent anti… 
2003
2003
P-16 未承認薬 temozolomide の再発性脳腫瘍に対する治療効果について